Entries for December 2015

Today, predictive molecular testing is available for 35 per cent of all tumour types

In future, high-quality medical research will only be achieved in conjunction with biobanks

14 December 2015. “Today, we have predictive biomarkers that enable targeted therapies for 35 per cent of all tumour types. Biobanks are the basis for this achievement,” stated Professor Manfred Dietel (Charité University Hospital, Berlin) in his keynote address at the fourth National Biobank Symposium. The event took place on 9 and 10 December 2015 in the German capital. “The positive evolution of this event demonstrates the importance biobanks have gained in recent years. In future, biobanks will be key to high-quality research,” emphasised Professor Michael Krawczak (University Medical Centre, Schleswig-Holstein, Kiel Campus), who, as Chairman of the TMF Board of Directors, opened the Symposium.